Trial Profile
Pharmacokinetics of transdermal and oral rivastigmine in patients with Alzheimer's disease.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jan 2011
Price :
$35
*
At a glance
- Drugs Rivastigmine (Primary) ; Rivastigmine (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- 10 Jan 2011 New trial record
- 25 Sep 2010 Results presented at the 14th Congress of the European Federation of Neurological Societies.